CLBT — Cellebrite DI Income Statement

0.000.00%

Last trade - 00:00

TechnologyAdventurousLarge CapNeutral

Annual income statement for Cellebrite DI, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st	2025 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	PROSPECTUS	20-F	20-F	20-F	20-F
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	246	271	325	401	476
Cost of Revenue
Gross Profit	204	220	272	339	401
Selling / General / Administrative Expenses
Research And Development
Depreciation and Amortization
Unusual Expense / Income
Total Operating Expenses	232	270	292	344	409
Operating Profit	13.8	1.04	33.2	56.9	66.5
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	82.3	121	-75.6	-276	90.7
Provision for Income Taxes
Net Income After Taxes	71.4	121	-81.1	-283	78.3
Net Income Before Extraordinary Items
Net Income	71.4	121	-81.1	-283	78.3
Adjustments to Net Income
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Dilution Adjustment
Diluted Net Income	70.4	116	-81.1	-283	77.8
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	0.431	0.616	-0.426	-1.35	0.327
Dividends per Share